LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.06 | 27.76 | 765 | 360 | 2.1250 | 1.4523 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 8.76 | 27.76 | 732 | 401 | 1.8248 | 1.3379 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 8.76 | 27.76 | 860 | 401 | 2.1439 | 1.4377 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 10.46 | 27.76 | 3 | 438 | 0.0068 | -0.4281 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 10.46 | 27.76 | 814 | 438 | 1.8557 | 1.3359 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 10.46 | 27.76 | 903 | 438 | 2.0586 | 1.3976 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 12.17 | 27.76 | 2 | 489 | 0.0041 | -0.4703 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 12.17 | 27.76 | 840 | 489 | 1.7175 | 1.2792 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 12.17 | 27.76 | 2 | 489 | 0.0041 | -0.4703 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 12.17 | 27.76 | 979 | 489 | 2.0018 | 1.3651 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 13.87 | 27.76 | 5 | 604 | 0.0083 | -0.3200 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 13.87 | 27.76 | 957 | 604 | 1.5826 | 1.2176 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 13.87 | 27.76 | 4 | 604 | 0.0066 | -0.3533 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 13.87 | 27.76 | 1057 | 604 | 1.7479 | 1.2677 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 15.58 | 27.76 | 10 | 685 | 0.0146 | -0.1980 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 15.58 | 27.76 | 997 | 685 | 1.4543 | 1.1686 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 15.58 | 27.76 | 4 | 685 | 0.0058 | -0.3421 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 15.58 | 27.76 | 1112 | 685 | 1.6220 | 1.2204 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 17.28 | 27.76 | 66 | 838 | 0.0787 | 0.1926 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 17.28 | 27.76 | 1090 | 838 | 1.2996 | 1.1095 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 17.28 | 27.76 | 1 | 838 | 0.0012 | -0.4913 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 17.28 | 27.76 | 1134 | 838 | 1.3521 | 1.1265 | MN20160318_Q01 | F13 |